Range Cancer Therapeutics Etf (CNCR)

  • $

$11.68

(-5.55%)

past 7 days

1D

1W

1M

1Y

3Y

5Y

Performance

  • $11.6284
    $ 11.82
    downward going graph

    0.44%

    Downside

    Day's Volatility :1.62%

    Upside

    1.18%

    downward going graph
  • $11.38
    $ 17.9599
    downward going graph

    2.57%

    Downside

    52 Weeks Volatility :36.64%

    Upside

    34.97%

    downward going graph

Expense Ratio

0.79%

AUM

$9.97M

Returns

PeriodRange Cancer Therapeutics EtfS&P500
3 Months
-24.95%
-0.03%
6 Months
-23.28%
5.34%
1 Year
-15.63%
23.27%
3 Years
-42.85%
27.54%

Top 10 Holdings

Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals Inc
3.5%
Vor Biopharma Inc
Vor Biopharma Inc
2.59%
Exelixis Inc
Exelixis Inc
2.2%
SpringWorks Therapeutics Inc
SpringWorks Therapeutics Inc
2.03%
Precigen Inc
Precigen Inc
1.97%
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company
1.88%
Replimune Group Inc
Replimune Group Inc
1.78%
ZYMEWORKS DL-00001
ZYMEWORKS DL-00001
1.77%
Compass Therapeutics Inc.
Compass Therapeutics Inc.
1.74%
Genelux Corporation Common Stock
Genelux Corporation Common Stock
1.71%

  • Market Cap

  • Assets

About the ETF

About Range Cancer Therapeutics Etf

About Range Cancer Therapeutics Etf

Range Cancer Therapeutics Etf has 1.0 ETFs with total asset size of $9.97M

Discover more

Frequently Asked Questions

What is Range Cancer Therapeutics Etf (CNCR) share price today?

Can Indians buy Range Cancer Therapeutics Etf shares?

How can I buy Range Cancer Therapeutics Etf shares from India?

Can Fractional shares of Range Cancer Therapeutics Etf be purchased?

What are the documents required to start investing in Range Cancer Therapeutics Etf stocks?

What are today’s High and Low prices of Range Cancer Therapeutics Etf?

What is today’s market capitalisation of Range Cancer Therapeutics Etf?

What is the 52 Week High and Low Range of Range Cancer Therapeutics Etf?

How much percentage Range Cancer Therapeutics Etf is down from its 52 Week High?

How much percentage Range Cancer Therapeutics Etf is up from its 52 Week low?